Investigating Ultrastructural Collagen Changes in Osteogenesis Imperfecta

研究成骨不全症中胶原蛋白的超微结构变化

基本信息

项目摘要

DESCRIPTION (provided by applicant): The lack of understanding of how altered collagen structure in Osteogenesis Imperfecta (Ol) translates to insufficiencies in tissue integrity is a critical impediment to the implementation of treatment protocols designed to return bone properties to normal levels. The long-term goal is to understand how alterations in the bone ultrastructure in Ol influence higher level properties. The overall objective of this proposal is to relate [morphological changes] in Type I collagen fibrils from connective tissues of Ol mice [to fibril mechanical integrity and] the altered ability of proteins to bind to this collagen as measures of functional competence. The central hypothesis is that alterations in the [width, axial spacing and packing] of Ol Type I collagen fibrils will result in inappropriate organic matrix organization, [decreased fibril modulus] and [improper protein binding to diseased fibril] surfaces. The rationale for the proposed research is that once mechanical differences in Ol [tissues] can be linked to explicit changes in Type I collagen, appropriate treatment options can be developed to specifically target altered collagen functions. Therefore, this research is relevant to the NIH's mission to apply fundamental knowledge about the nature of living systems to extending healthy human life and reducing the burdens of illness and disability. Based on strong preliminary data and a solid literature base, the central hypothesis will be tested by pursuing two specific aims: 1) Identify morphological and organizational consequences of Ol in Type I collagen; and 2) Establish changes [in mechanical integrity and] in the ability of proteins to bind to Type I collagen in Ol as measures of functional competence. Atomic force microscopy coupled with dendritic polymers as model proteins will be used to probe the collagen of wild type, [Brtl/+] and [Brtl/Brtl] mice representing a [range] of Ol severity. Under the first aim, Type I collagen will be imaged in a variety of biological settings to determine how collagen physically [changes with mutation severity]. Under the second aim, physical differences in collagen will be correlated [with fibril modulus and] with alterations in the ability of proteins to bind to fibril surfaces as measures of functionality. The approach is innovative because it will begin linking architectural and functional aspects of Type I collagen at the ultrastructural level to higher-level properties in situ. As the United States is part of the current worldwide Bone and Joint Decade initiative, this research has clear relevance to public health. Uncovering the link between bone quality and structural integrity remains a key goal of the bone research community. Therefore, this research is not only applicable to Ol patients, but has broader implications for investigating other diseases related to ultrastructural modifications of bone.
描述(由申请人提供):缺乏对成骨不全症(Ol)中胶原结构改变如何转化为组织完整性缺陷的了解,是实施旨在使骨特性恢复到正常水平的治疗方案的关键障碍。长期目标是了解 Ol 骨超微结构的变化如何影响更高水平的特性。该提案的总体目标是将 Ol 小鼠结缔组织的 I 型胶原原纤维的[形态变化]与原纤维机械完整性和蛋白质与胶原蛋白结合能力的改变联系起来,作为功能能力的衡量标准。中心假设是I型胶原原纤维[宽度、轴向间距和堆积]的改变将导致不适当的有机基质组织、[原纤维模量降低]和[与患病原纤维的不适当的蛋白质结合]表面。拟议研究的基本原理是,一旦 Ol [组织] 的机械差异可以与 I 型胶原蛋白的显着变化联系起来,就可以开发适当的治疗方案来专门针对改变的胶原蛋白功能。因此,这项研究与美国国立卫生研究院的使命相关,即应用有关生命系统本质的基础知识来延长人类的健康寿命并减轻疾病和残疾的负担。基于强有力的初步数据和坚实的文献基础,中心假设将通过追求两个具体目标来检验:1) 识别 I 型胶原蛋白中 Ol 的形态和组织后果; 2) 确定 Ol 中蛋白质与 I 型胶原蛋白结合能力的变化(机械完整性和),作为功能能力的衡量标准。原子力显微镜与作为模型蛋白的树突状聚合物相结合将用于探测代表Ol严重程度[范围]的野生型、[Brtl/+]和[Brtl/Brtl]小鼠的胶原蛋白。第一个目标是,I 型胶原蛋白将在各种生物环境中进行成像,以确定胶原蛋白的物理变化[随突变严重程度的变化]。在第二个目标下,胶原蛋白的物理差异将与[与原纤维模量和]蛋白质与原纤维表面结合的能力的变化相关,作为功能性的测量。该方法具有创新性,因为它将开始将超微结构水平上的 I 型胶原蛋白的结构和功能方面与原位更高水平的特性联系起来。由于美国是当前全球“骨骼与关节十年”倡议的一部分,因此这项研究与公共卫生具有明显的相关性。揭示骨骼质量和结构完整性之间的联系仍然是骨骼研究界的一个关键目标。因此,这项研究不仅适用于Ol患者,而且对研究与骨超微结构改变相关的其他疾病具有更广泛的意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Michael Wallace其他文献

Joseph Michael Wallace的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph Michael Wallace', 18)}}的其他基金

Improving bone mass and quality in comorbid diabetes and chronic kidney disease
改善糖尿病和慢性肾病共病患者的骨量和骨质量
  • 批准号:
    10590035
  • 财政年份:
    2023
  • 资助金额:
    $ 4.56万
  • 项目类别:
Targeting collagen as an interventional approach to improve bone material properties
将胶原蛋白作为改善骨材料特性的介入方法
  • 批准号:
    10407622
  • 财政年份:
    2018
  • 资助金额:
    $ 4.56万
  • 项目类别:
Targeting collagen as an interventional approach to improve bone material properties
将胶原蛋白作为改善骨材料特性的介入方法
  • 批准号:
    10159215
  • 财政年份:
    2018
  • 资助金额:
    $ 4.56万
  • 项目类别:
Targeting collagen as an interventional approach to improve bone material properties
以胶原为靶点作为改善骨材料特性的介入方法
  • 批准号:
    9926823
  • 财政年份:
    2018
  • 资助金额:
    $ 4.56万
  • 项目类别:
Investigating Ultrastructural Collagen Changes in Osteogenesis Imperfecta
研究成骨不全症中胶原蛋白的超微结构变化
  • 批准号:
    7663985
  • 财政年份:
    2008
  • 资助金额:
    $ 4.56万
  • 项目类别:

相似海外基金

Using epigenetic science to improve environmental health literacy
利用表观遗传学提高环境健康素养
  • 批准号:
    10524680
  • 财政年份:
    2023
  • 资助金额:
    $ 4.56万
  • 项目类别:
Translational genomics in gout: From GWAS signal to mechanism
痛风的转化基因组学:从 GWAS 信号到机制
  • 批准号:
    10735151
  • 财政年份:
    2023
  • 资助金额:
    $ 4.56万
  • 项目类别:
Structural analysis of the human LRRK2
人类 LRRK2 的结构分析
  • 批准号:
    10734733
  • 财政年份:
    2023
  • 资助金额:
    $ 4.56万
  • 项目类别:
Diurnal Variation in Acetylcholine Modulation of Dopamine Dynamics Following Chronic Cocaine Intake
慢性可卡因摄入后乙酰胆碱对多巴胺动力学调节的昼夜变化
  • 批准号:
    10679573
  • 财政年份:
    2023
  • 资助金额:
    $ 4.56万
  • 项目类别:
Characterizing the prevalence and nature of facial recognition deficits in non-proliferative diabetic retinopathy
描述非增殖性糖尿病视网膜病变中面部识别缺陷的患病率和性质
  • 批准号:
    10667781
  • 财政年份:
    2023
  • 资助金额:
    $ 4.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了